Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Non Operating Income: 2017-2024

Historic Non Operating Income for Puma Biotechnology (PBYI) over the last 8 years, with Dec 2024 value amounting to -$6.9 million.

  • Puma Biotechnology's Non Operating Income rose 77.57% to -$330,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year increase of 65.80%. This contributed to the annual value of -$6.9 million for FY2024, which is 31.11% up from last year.
  • Puma Biotechnology's Non Operating Income amounted to -$6.9 million in FY2024, which was up 31.11% from -$10.0 million recorded in FY2023.
  • Over the past 5 years, Puma Biotechnology's Non Operating Income peaked at -$6.9 million during FY2024, and registered a low of -$30.1 million during FY2021.
  • Over the past 3 years, Puma Biotechnology's median Non Operating Income value was -$10.0 million (recorded in 2023), while the average stood at -$13.4 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first declined by 2.40% in 2021, then surged by 57.16% in 2023.
  • Yearly analysis of 5 years shows Puma Biotechnology's Non Operating Income stood at -$29.4 million in 2020, then decreased by 2.40% to -$30.1 million in 2021, then grew by 22.69% to -$23.3 million in 2022, then soared by 57.16% to -$10.0 million in 2023, then surged by 31.11% to -$6.9 million in 2024.